Navin Katyal

Navin Katyal is the current US Primary Care President at Pfizer, where they lead the US Primary Care Business, overseeing vaccines, treatments for infectious diseases, and various medications. Previously, they held significant roles at Pfizer, including Regional President of the North America Hospital Business and Global mRNA Business Lead, managing commercial strategy for COVID-19 vaccines. Navin's earlier experience includes a managerial position at Accenture in the Health and Life Sciences Consulting Practice. They earned an MBA from Columbia University - Columbia Business School.